Utilization of Green Synthesized Chitosan Gold Nanoparticles for Oral Cancer Treatment Using Laser Flow Cytometry: In-Vitro Study

Document Type : Original Article

Authors

1 Department of Medical Applications of Laser, National Institute of Laser Enhanced Sciences (NILES), Cairo University

2 Cairo University

3 National Institute of Laser Enhanced Sciences (NILES), Cairo University, Giza, Egypt

4 Microbiology Department, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt

5 Department of laser sciences and interactions, National Institute of Laser Enhanced Sciences (NILES), Cairo University

Abstract

This study reports the eco-friendly synthesis, comprehensive characterization, and in vitro cytotoxic evaluation of chitosan-reduced gold nanoparticles (Cs@AuNPs). Cs@AuNPs were synthesized by reducing chloroauric acid using chitosan as both a reducing and stabilizing agent, yielding a stable ruby-red colloidal solution. The formation of nanoparticles was confirmed by UV-Visible spectroscopy, with a surface plasmon resonance peak observed at 522 nm. Transmission electron microscopy revealed spherical nanoparticles with a size distribution of 14 ± 2 nm, while zeta potential measurements indicated high colloidal stability (+28 mV). FTIR analysis confirmed the involvement of chitosan’s amino and hydroxyl functional groups in the reduction and stabilization processes. The cytotoxic potential of Cs@AuNPs was assessed using the sulforhodamine B (SRB) assay on oral epithelial cells (OEC), revealing dose-dependent effects with acceptable cell viability at concentrations up to 100 μg/mL. Further analysis using Annexin V-FITC/PI flow cytometry demonstrated that Cs@AuNPs induced apoptosis in a concentration-dependent manner, with early and late apoptotic populations clearly distinguishable. These findings highlight the biocompatibility and potential therapeutic application of Cs@AuNPs, suggesting their suitability for further development in cancer diagnostics and targeted delivery systems.

Keywords

Main Subjects



Articles in Press, Accepted Manuscript
Available Online from 02 October 2025
  • Receive Date: 30 July 2025
  • Revise Date: 01 September 2025
  • Accept Date: 02 October 2025